Castle Biosciences, Inc. Common Stock vs. Quest Diagnostics Inc.
CSTL
Castle Biosciences, Inc. Common Stock
$35.75 -2.80%
VS DGXQuest Diagnostics Inc.
$246.45 -0.40%
Quest Diagnostics Inc. (DGX) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| CSTL | DGX | |
|---|---|---|
| Market Cap | $1.12 billion | $27.31 billion |
| Revenue (TTM) | $357.28 million | $11.56 billion |
| Net Income (TTM) | $-19,415,000 | $1.11 billion |
DGX leads on 3 of 3 size & scale factors.
Valuation
| CSTL | DGX | |
|---|---|---|
| P/E Ratio | — | 26.16 |
| Price / Book | 2.39 | 3.49 |
| Price / Sales | 3.14 | 2.36 |
CSTL and DGX split the valuation factors evenly.
Profitability
| CSTL | DGX | |
|---|---|---|
| Net Margin | -5.43% | 9.63% |
| Return on Equity | -4.13% | 14.23% |
DGX leads on 2 of 2 profitability factors.
Dividend
| CSTL | DGX | |
|---|---|---|
| Dividend Yield | — | 1.40% |
| Payout Ratio | — | 36.52 |
CSTL and DGX split the dividend factors evenly.
Risk & Sentiment
| CSTL | DGX | |
|---|---|---|
| Short Interest | 0.04% | 4.76% |
CSTL leads on 1 of 1 risk & sentiment factors.
Dig deeper: CSTL overview, CSTL financials, DGX overview, DGX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.